[EN] DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF [FR] INHIBITEURS DE LA DÉSUBIQUITINASE ET LEURS PROCÉDÉS D'UTILISATION
摘要:
The inventive compounds of formula (I) are small molecule therapeutics that are potent inhibitors of USP7 activity. The invention also provides pharmaceutical compositions comprising the compounds (I), and methods for using the compounds for treating or preventing a disease, disorder, or condition associated with USP7 activity.
[EN] DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF [FR] INHIBITEURS DE LA DÉSUBIQUITINASE ET LEURS PROCÉDÉS D'UTILISATION
摘要:
The inventive compounds of formula (I) are small molecule therapeutics that are potent inhibitors of USP7 activity. The invention also provides pharmaceutical compositions comprising the compounds (I), and methods for using the compounds for treating or preventing a disease, disorder, or condition associated with USP7 activity.
[EN] 1-(HET)ARYLSULFONYL-(PYRROLIDINE OR PIPERIDINE)-2-CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS<br/>[FR] DÉRIVÉS DE 1-(HET)ARYLSULFONYLE- (PYRROLIDINE OU PIPÉRIDINE)-2-CARBOXAMIDE ET LEUR UTILISATION COMME ANTAGONISTES DE TRPA1
申请人:HOFFMANN LA ROCHE
公开号:WO2016128529A1
公开(公告)日:2016-08-18
The invention is concerned with the compounds of formula I and salts thereof and other compounds of formulas II-IX as disclosed herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formulas I-IX as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain or asthma.